Patient Advocates Say ICER Uses Discriminatory Cost Metrics

By Rachel Cohrs / June 27, 2019 at 11:31 AM

A coalition of patient advocates, provider groups and drug makers is criticizing the Institute for Clinical and Economic Review for using a metric they say discriminates against people with disabilities and chronic illness.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.